Product Information
NUCYNTA 100 MG TABLET is a brand product labeled by Collegium Pharmaceutical, Inc., priced at $15.7978 per EA under NDC 24510010010. Its NADAC has been published 281 times since Aug 21, 2019.
FDA first approved this application on Nov 20, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Collegium Pharmaceutical, Inc.NDC
24510010010
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
12/18/2024
Active Ingredients
TAPENTADOL HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA022304FDA Approved
11/20/2008
TE Code
AB
On Market Since
4/1/2019
Pharmacological Classes
Price Statistics
The NADAC for NUCYNTA 100 MG TABLET has been published 281 times since Aug 21, 2019, and over the history we have for it it has risen 65.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $15.7978 per EA |
|---|---|
| All-time high | $15.8167 (Jun 12, 2024) |
| All-time low | $9.4925 (Oct 23, 2019) |
| Median price | $13.1732 |
| Average price | $12.7939 |
| Largest weekly change | +15.0% (Jan 12, 2022) |
| Weeks tracked | 281 |
| Tracking since | Aug 21, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+10.0%
5Y
+37.8%
All
+65.9%
Last surveyed Jan 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Collegium Pharmaceutical, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
tapentadol hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NUCYNTA 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NUCYNTA 100 MG TABLET, manufactured by Collegium Pharmaceutical, Inc., is $15.7978 per EA (NDC 24510010010), effective Jan 1, 2025.
How has the price of NUCYNTA 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for NUCYNTA 100 MG TABLET has risen 65.9%. It has been tracked across 281 weekly CMS publications since Aug 21, 2019.
What are the highest and lowest recorded NADAC prices for NUCYNTA 100 MG TABLET?
Since Aug 21, 2019, the NADAC for NUCYNTA 100 MG TABLET has ranged from a low of $9.4925 (Oct 23, 2019) to a high of $15.8167 (Jun 12, 2024), with a median of $13.1732 per EA.
Are there cheaper alternatives to NUCYNTA 100 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as NUCYNTA 100 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures NUCYNTA 100 MG TABLET?
NUCYNTA 100 MG TABLET (NDC 24510010010) is labeled by Collegium Pharmaceutical, Inc., and CMS classifies it as a brand product.